These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2138994)

  • 21. High-dose chemotherapy with noncryopreserved autologous bone marrow transplantation for acute myeloid leukemia in first complete remission.
    Koeppler H; Pflueger KH; Wolf M; Weide R; Havemann K
    Haematol Blood Transfus; 1990; 33():699-701. PubMed ID: 2323669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proposal for the classification of relapsed and refractory acute myeloid leukemias as the basis for an age-adjusted randomized comparison of sequentially applied high-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone (S-HAM).
    Hiddemann W; Aul HC; Maschmeyer G; Urbanitz D; Lathan B; Reichle A; Köppler H; Donhuijsen-Ant R; Ludwig WD; Grüneisen T
    Haematol Blood Transfus; 1990; 33():604-10. PubMed ID: 2182450
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study].
    Stahnke K; Ritter J; Schellong G; Beck JD; Kabisch H; Lampert F; Creutzig U
    Klin Padiatr; 1992; 204(4):253-7. PubMed ID: 1518261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cure of acute myeloblastic leukemia in a child with Down syndrome and tetralogy of Fallot].
    Balcar-Boroń A; Nowaczyk-Michalak A; Graduszewska-Czerebiej K
    Wiad Lek; 1992 Mar; 45(5-6):220-3. PubMed ID: 1455866
    [No Abstract]   [Full Text] [Related]  

  • 25. High-dose retinol in children with acute myelogenous leukemia in remission.
    Lie SO; Wathne KO; Petersen LB; Slørdahl SH; Norum KR
    Eur J Haematol; 1988 May; 40(5):460-5. PubMed ID: 3163976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group.
    Zittoun R; Mandelli F; Willemze R; de Witte T; Tura S; Ferrini PR; Stryckmans P; Gattringer C; Petti MC; Solbu G
    Leukemia; 1992; 6 Suppl 2():114-5. PubMed ID: 1578909
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of recurrent acute myelogenous leukaemia at a single centre over a 10-year period.
    Davis CL; Rohatiner AZ; Amess J; Lim J; Lister TA
    Haematol Blood Transfus; 1990; 33():339-41. PubMed ID: 2323639
    [No Abstract]   [Full Text] [Related]  

  • 28. Double intensive consolidation chemotherapy (ICC) for acute myeloid leukemia.
    Harousseau JL; Milpied N; Briere J; Desablens B; Le Prise PY; Ifrah N; Gandhour C; Casassus P
    Haematol Blood Transfus; 1990; 33():299-303. PubMed ID: 2323633
    [No Abstract]   [Full Text] [Related]  

  • 29. Mitoxantrone and etoposide in patients with relapsed and refractory acute nonlymphocytic leukemia.
    Rowe JM; Mazza JJ; Hines JD; Cassileth PA; Oken MM; Bennett JM; Andersen J
    Haematol Blood Transfus; 1990; 33():326-9. PubMed ID: 2182427
    [No Abstract]   [Full Text] [Related]  

  • 30. Double autologous bone marrow transplantation in acute myeloid leukaemia.
    Gribben JG; Goldstone AH; Linch DC; MacMillan AK; Richards JD
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():209-11. PubMed ID: 2653506
    [No Abstract]   [Full Text] [Related]  

  • 31. Predictive models for achievement of complete remission and duration of first remission in adult acute myeloid leukemia.
    Heinecke A; Sauerland MC; Büchner T
    Haematol Blood Transfus; 1990; 33():285-9. PubMed ID: 2182422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose cytosine arabinoside in the treatment of acute myelogenous leukemia: contributions to outcome of clinical and laboratory attributes.
    Curtis JE; Messner HA; Minden MD; Minkin S; McCulloch EA
    J Clin Oncol; 1987 Apr; 5(4):532-43. PubMed ID: 3549988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MEC (mitoxantrone, etoposide and intermediate dose cytarabine): an effective induction regimen for previously untreated acute non-lymphocytic leukemia.
    Visani G; Petti MC; Cenacchi A; Manfroi S; Tosi P; Spadea A; Latagliata R; Amadori S; Mandelli F; Tura S
    Leuk Lymphoma; 1995 Nov; 19(5-6):447-51. PubMed ID: 8590845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of postremission therapies in adult acute myeloid leukemia: preliminary analysis of an ECOG study. Eastern Cooperative Oncology Group.
    Cassileth PA; Harrington DP; Hines JD; Oken MM; Mazza JJ; McGlave P; Bennett JM; Lynch E; O'Connell MJ
    Haematol Blood Transfus; 1990; 33():267-70. PubMed ID: 2182420
    [No Abstract]   [Full Text] [Related]  

  • 35. Continuous and high-dose cytarabine combined chemotherapy in children with down syndrome and acute myeloid leukemia: Report from the Japanese children's cancer and leukemia study group (JCCLSG) AML 9805 down study.
    Taga T; Shimomura Y; Horikoshi Y; Ogawa A; Itoh M; Okada M; Ueyama J; Higa T; Watanabe A; Kanegane H; Iwai A; Saiwakawa Y; Kogawa K; Yamanaka J; Tsurusawa M
    Pediatr Blood Cancer; 2011 Jul; 57(1):36-40. PubMed ID: 21557456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensive timed sequential remission induction chemotherapy with high-dose cytarabine for childhood acute myeloid leukemia.
    Loeb DM; Bowers DC; Civin CI; Friedman AD
    Med Pediatr Oncol; 2001 Oct; 37(4):365-71. PubMed ID: 11568900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of the Italian AIEOP/LAM 8204 study for the treatment of childhood AML: an update.
    Amadori S; Mandelli F; Ceci A; Comelli A; Madon E; Masera G; Nespoli L; Paolucci G; Zanesco L; Defazio D
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():114-5. PubMed ID: 2653484
    [No Abstract]   [Full Text] [Related]  

  • 38. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.
    Ravindranath Y; Chang M; Steuber CP; Becton D; Dahl G; Civin C; Camitta B; Carroll A; Raimondi SC; Weinstein HJ;
    Leukemia; 2005 Dec; 19(12):2101-16. PubMed ID: 16136167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of acute myelogenous leukemia in children: results of the Italian Cooperative Study AIEOP/LAM 8204.
    Amadori S; Ceci A; Comelli A; Madon E; Masera G; Nespoli L; Paolucci G; Zanesco L; Covelli A; Mandelli F
    J Clin Oncol; 1987 Sep; 5(9):1356-63. PubMed ID: 3476689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What's up with down syndrome and leukemia-A lot!
    Taub JW; Ravindranath Y
    Pediatr Blood Cancer; 2011 Jul; 57(1):1-3. PubMed ID: 21480471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.